Vasculitides Flashcards
Clinical features of Polyarteritis nodosa
Sudden sharp pain in peripheral nerve distribution, later with weakness (foot drop). Cutaneous manifestations: palpable purpura, infarctive ulcers, Livedo reticularis, Digital tip infarctions, Livedo Reticularis, Mononeuritis Multiplex, Cutaneous Nodules
Management of Polyarteritis nodosa
Treatment: High dose steroids (1 mg/kg/day), Immunosuppressives, such as cyclophosphamide or azathioprine, Plasma exchange; Treat viral hepatitis if present.
Polyarteritis nodosa
Skin, peripheral nerves, joints, intestinal tract most commonly involved. Lungs spared. Uncommon- incidence 5 to 10 per million per year, Twice as common in men. ……. Assoc w/ Hep B (more commonly prior to vaccine)
Can affect myriad of organs (GU, abd, ocular), Musculoskeletal – arthralgias»_space; synovitis, “Mononeuritis multiplex” >50%.
Pathology of Hypersensitivity vasculitis (LCV)
Extravasated RBCs, fibrinoid necrosis
Clinical features of Hypersensitivity vasculitis (LCV)
Pts with LCV complain of: itching, burning sensation
pain, asymptomatic lesions …………… Exam: Palpable purpura most common, Lesions usually round 1-3 mm diameter, May coalesce, plaque like, May ulcerate
Management of Hypersensitivity vasculitis (LCV)
Treat the cause (if you can find it!); Generally results in rapid clearing in 2 wks. Treat chronic disease that primarily involves the skin with nontoxic modalities. Try to minimize systemic steroids, Avoid immunosuppressives. Colchicine or dapsone (inhib neutrophil fxn)
Hypersensitivity vasculitis (LCV)
Leukocytoclastic vasculitis (LCV) - histopathologic term denoting small-vessel vasculitis.“Cutaneous vasculitis” “LCV” “Hypersensitivity vasculitis: all terms are used interchangeably. Many possible causes exist for this condition, but a cause is not found in as many as 50% of patients . The most commonly identified cause is a drug reaction ……. Various infections such as Hep C. Collagen Vascular Diseases (RA, Sjogrens, Lupus). Inflammatory Bowel Disease. Malignancy accounts for less than 1% of cases of cutaneous vasculitis.
Cryoglobulinemia
Cryoglobulins – immunoglobulins & complement. Precipitation of blood proteins at temps <37C, Dissolve upon warming – tend to see peripheral involvement
Etiology of Cryoglobulinemia
Chronic immune stimulation, defective clearance. Associated with hepatitis B & C
Clinical features of Cryoglobulinemia
Prognonis is good, 70% at 10 yrs. Severe manifestations:
Glomerulonephritis , tends to be assoc Hep C, GI (abd pain, bleeding), Rapidly progressive neuropathy, CHF
Management of Cryoglobulinemia
Labs: + cryoglobulins, Diminished complement, +RF, Hepatitis B & C, Renal failure, Lymphoproliferative d/o……….
Treatment: tx underlying hepatitis, malignancy, Prednisone (tapered rapidly), Rituxan if severe.
Labs and Imaging of Wegner’s Granulomatosis
Renal: increased Scr, proteinuria, hematuria, red blood cell casts; + c-ANCA PR3 80-90%, most often with active disease; Anemia; Elevated inflammtory markers; Chest CT - nodules and infiltrations that often cavitate
Diagnosis of Wegner’s Granulomatosis
Suspect with upper or lower respiratory tract involvement and nasal/oral ulcerations; PR3 positive c-ANCA; Biopsy of involved tissues - necrotizing granulomatous inflammatory process
Clinical Manifestations of Wegner’s Granulomatosis
Nonspecific findings- fever, malaise, weight loss, arthralgias, myalgias, chronic rhinitis or worsening sinusitis. Pain over sinus areas. ………… Purulent or bloody nasal discharge. Nasal or mucosal ulcerations. Saddle-nose deformity …….. Pulmonary: chest pain, dyspnea, hemoptysis, pulmonary hemorrhage, Tracheal lesions and subglottic involvement -> stenosis. ………. Eye- uveitis, episcleritis, proptosis
Management of Wegner’s Granulomatosis
High dose steroids (1mg/kg or IV 1g/d x3d). Immunosuppressives, such as Cyclophosphamide or Rituximab. Diffuse alveolar hemorrhage – plasmapharesis
Relapses common, maintenance therapy with less toxic drugs (methotrexate or azathioprin)